Fisher & Paykel Healthcare Co. Limited (OTCMKTS:FSPKF – Get Free Report) was the target of a large decline in short interest in the month of July. As of July 15th, there was short interest totaling 8,056 shares, a decline of 53.5% from the June 30th total of 17,343 shares. Based on an average trading volume of 1,382 shares, the short-interest ratio is presently 5.8 days.
Fisher & Paykel Healthcare Stock Performance
Shares of FSPKF remained flat at $22.96 during mid-day trading on Wednesday. 3,230 shares of the company were exchanged, compared to its average volume of 3,247. Fisher & Paykel Healthcare has a 12-month low of $19.01 and a 12-month high of $25.69. The company has a 50-day moving average of $22.13 and a two-hundred day moving average of $22.63.
Fisher & Paykel Healthcare Company Profile
Fisher & Paykel Healthcare Corporation Limited is a New Zealand-based medical device company that specializes in the design, manufacture and marketing of products and systems for respiratory care and the treatment of obstructive sleep apnea. Headquartered in Auckland, the company focuses on delivering therapeutic solutions that enhance patient outcomes across a range of acute and chronic respiratory conditions.
The company’s product portfolio includes humidification systems used in mechanical ventilation, high-flow nasal cannula therapy devices for adult and neonatal care, continuous positive airway pressure (CPAP) machines and interfaces for sleep apnea treatment, as well as medical devices for non-invasive ventilation.
Further Reading
- Five stocks we like better than Fisher & Paykel Healthcare
- Why SK hynix Could Be the Best AI Chip Stock to Buy Now
- Seagate Technology Stock Surges as Earnings Beat Silences AI Doubters
- Alphabet Is Down 18% From Its High After a Stellar Quarter—Overdone, or More Downside Ahead?
- Why Bloom Energy May Be the Most Important AI Infrastructure Stock
Receive News & Ratings for Fisher & Paykel Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fisher & Paykel Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
